| Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies … L Cooley, C Dendle, J Wolf, BW Teh, SC Chen, C Boutlis, KA Thursky Internal medicine journal 44 (12b), 1350-1363, 2014 | 252 | 2014 |
| Managing haematology and oncology patients during the COVID‐19 pandemic: interim consensus guidance R Weinkove, ZK McQuilten, J Adler, MR Agar, E Blyth, AC Cheng, ... Medical Journal of Australia 212 (10), 481-489, 2020 | 164 | 2020 |
| Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy BW Teh, SJ Harrison, LJ Worth, T Spelman, KA Thursky, MA Slavin British journal of haematology 171 (1), 100-108, 2015 | 130 | 2015 |
| Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines KL Flanagan, E Best, NW Crawford, M Giles, A Koirala, K Macartney, ... Frontiers in immunology 11, 579250, 2020 | 117 | 2020 |
| Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies BW Teh, JC Teng, K Urbancic, A Grigg, SJ Harrison, LJ Worth, MA Slavin, ... Haematologica 100 (1), e28, 2015 | 77 | 2015 |
| Infections in patients with chronic lymphocytic leukaemia: mitigating risk in the era of targeted therapies BW Teh, CS Tam, S Handunnetti, LJ Worth, MA Slavin Blood reviews 32 (6), 499-507, 2018 | 75 | 2018 |
| Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis JSK Teh, J Coussement, ZCF Neoh, T Spelman, S Lazarakis, MA Slavin, ... Blood Advances 6 (7), 2014-2034, 2022 | 66 | 2022 |
| Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection BW Teh, SJ Harrison, M Pellegrini, KA Thursky, LJ Worth, MA Slavin Blood Reviews 28 (2), 75-86, 2014 | 66 | 2014 |
| CAR-T cell therapy and infection: a review O Bupha-Intr, G Haeusler, L Chee, K Thursky, M Slavin, B Teh Expert Review of Anti-Infective Therapy 19 (6), 749-758, 2021 | 65 | 2021 |
| Implementation of a whole of hospital sepsis clinical pathway in a cancer hospital: impact on sepsis management, outcomes and costs K Thursky, S Lingaratnam, J Jayarajan, GM Haeusler, B Teh, M Tew, ... BMJ open quality 7 (3), e000355, 2018 | 63 | 2018 |
| Infection risk with immunomodulatory and proteasome inhibitor–based therapies across treatment phases for multiple myeloma: A systematic review and meta-analysis BW Teh, SJ Harrison, LJ Worth, KA Thursky, MA Slavin European Journal of Cancer 67, 21-37, 2016 | 63 | 2016 |
| Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021 BW Teh, DK Yeoh, GM Haeusler, CK Yannakou, S Fleming, J Lindsay, ... Internal Medicine Journal 51, 67-88, 2021 | 57 | 2021 |
| Azole antifungals and new targeted therapies for hematological malignancy J Lindsay, BW Teh, K Micklethwaite, M Slavin Current opinion in infectious diseases 32 (6), 538-545, 2019 | 57 | 2019 |
| Impact of swine influenza and quarantine measures on patients and households during the H1N1/09 pandemic B Teh, K Olsen, J Black, AC Cheng, C Aboltins, K Bull, PDR Johnson, ... Scandinavian journal of infectious diseases 44 (4), 289-296, 2012 | 51 | 2012 |
| Epidemiology of invasive fungal disease in lymphoproliferative disorders JC Teng, MA Slavin, BW Teh, SM Lingaratnam, MR Ananda-Rajah, ... Haematologica 100 (11), e462, 2015 | 44 | 2015 |
| Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer … BW Teh, LJ Worth, SJ Harrison, KA Thursky, MA Slavin Supportive Care in Cancer 23, 1901-1906, 2015 | 37 | 2015 |
| Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy BW Teh, SJ Harrison, MA Slavin, LJ Worth European journal of haematology 98 (2), 149-153, 2017 | 36 | 2017 |
| Late‐onset Pneumocystis jirovecii pneumonia post–fludarabine, cyclophosphamide and rituximab: implications for prophylaxis GM Haeusler, MA Slavin, JF Seymour, S Lingaratnam, BW Teh, CS Tam, ... European journal of haematology 91 (2), 157-163, 2013 | 36 | 2013 |
| Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing SA Sim, VKY Leung, D Ritchie, MA Slavin, SG Sullivan, BW Teh Biology of Blood and Marrow Transplantation 24 (7), 1490-1496, 2018 | 32 | 2018 |
| Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization BW Teh, MA Slavin, SJ Harrison, LJ Worth Expert review of anti-infective therapy 13 (11), 1325-1336, 2015 | 31 | 2015 |
